The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

BENGALURU: Vaccines and antiviral, although not very effective are there for flu virus, however there are none which are clinically approved for mosquito borne ...

Maharashtra CM reviews GBS cases, instructs officials for treatment arrangements, and coverage under MJPJAY in government ...

India experiences the world’s absolute burden of at least 11 NTDs, including hookworm, dengue, lymphatic filariasis, leprosy, ...

A new case of Guillain-Barre Syndrome has been reported in Pune, raising concerns as health officials monitor the situation ...

First death in Maharashtra due to GBS; Pune reports 9 more cases, officials take preventive measures, water contamination ...

The health officials said that a new Guillain-Barre Syndrome case was reported in Pune on Tuesday; number of suspected GBS ...

Doctors report increased post-chikungunya complaints, necessitating long-term treatment for symptoms such ... terms of Chikungunya infections with the virus sickening as many as 5,757 people ...

A new Guillain-Barre Syndrome (GBS) case was reported in Pune on Tuesday, health officials said. The number of suspected GBS cases, thus, stood at 111, with 13 patients on ventilator, they said. “111 ...

EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance: Amsterdam, The Netherlands Saturday, January 18, 2025, 13:00 Hrs [IST] European Me ...

In Trial 072, treatment with brexpiprazole plus sertraline ... for active immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older.